Birth and neonatal outcomes following opioid use in pregnancy: A danish population-based study

Substance Abuse: Research and Treatment

Volumn 9, Issue , 2015, Pages 5-11

  Nørgaard, Mette ^a   Nielsson, Malene Schou ^a   Heide Jørgensen, Uffe ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Drug safety; Epidemiology; Opioid maintenance treatment; Pregnancy

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE;

ADULT; ADVERSE OUTCOME; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DANISH CITIZEN; DENMARK; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HEROIN DEPENDENCE; HUMAN; INFANT; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEONATAL OUTCOME; NEWBORN; OPIATE ADDICTION; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; POPULATION RESEARCH; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL EXPOSURE; PREVALENCE; RISK ASSESSMENT; SMALL FOR DATE INFANT; STILLBIRTH; WITHDRAWAL SYNDROME;

EID: 84946902774     PISSN: None     EISSN: 11782218     Source Type: Journal    
DOI: 10.4137/SaRt.S23547     Document Type: Article

References (24)

1. Reitox National Focal Point D. In: 2014 National Report (2013 data) to the EMCDDA. New Development, Trends. 2014.
2. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction. 1997;92(11):1571-9.
3. Minozzi S, Amato L, Vecchi S, Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev. 2008;12(2):CD006318.
4. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am. 1998;25(1):139-51.
5. Desai RJ, Huybrechts KF, Hernandez-Diaz S, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015;350:h2102.
6. Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol. 2015;125(2):363-8.
7. Patrick SW, Dudley J, Martin PR, et al. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135(5):842-50.
8. Jones HE, Heil SH, O'Grady KE, et al. Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples. Am J Drug Alcohol Abuse. 2009;35(5):375-80.
9. Jarvis MA, Schnoll SH. Methadone use during pregnancy. NIDA Res Monogr. 1995;149:58-77.
10. Cleary BJ, Eogan M, O'Connell MP, et al. Methadone and perinatal outcomes: a prospective cohort study. Addiction. 2012;107(8):1482-92.
11. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349(10):949-58.
12. Kayemba-Kay's S, Laclyde JP. Buprenorphine withdrawal syndrome in newborns: a report of 13 cases. Addiction. 2003;98(11):1599-604.
13. Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70(2 suppl):S87-101.
14. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320-31.
15. Jones HE, Heil SH, Baewert A, et al. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction. 2012;107(suppl 1):5-27.
16. Welle-Strand GK, Skurtveit S, Jones HE, et al. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Drug Alcohol Depend. 2013;127(1-3):200-6.
17. Knudsen LB, Olsen J. The Danish medical birth registry. Dan Med Bull. 1998;45:320-3.
18. Johansen AN, Stenzhorn AA, Rosenzweig M, Thirstrup S, Gazerani P. Prescribing patterns and safety monitoring of duloxetine using the Danish Register of Medicinal Product Statistics as a source. Scand J Public Health. 2013;41(8):866-73.
19. Statens Serum Institute. [homepage on the Internet]. Registry of Drug Abusers Undergoing Treatment. Available at http://www.ssi.dk/Sundhedsdataogit/Registre%20og%20kliniske%20databaser/De%20nationale%20sundhedsregistre/Sygdomme%20leagemidler%20behandlinger/Stofmisbrugere%20i%20behandling.aspx. Accessed June 13, 2015.
20. Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541-9.
21. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441-9.
22. Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sorensen HT. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health. 2003;31(1):12-6.
23. Jepsen B, Jepsen P, Johnsen SP, Espersen GT, Sørensen HT. Validity of recorded diagnoses of congenital cardiac malformations in a Danish population-based hospital-discharge registry. Int J Risk Saf Med. 2006;18:77-81.
24. Wilcox AJ. Birth weight and perinatal mortality: the effect of maternal smoking. Am J Epidemiol. 1993;137(10):1098-104.